CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
1.770
-0.080 (-4.32%)
Dec 5, 2025, 4:00 PM EST - Market closed
CytoMed Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 20 | 39 | 56 | - | - | - | |
| Market Cap Growth | -8.76% | -30.55% | - | - | - | - | |
| Enterprise Value | 19 | 35 | 49 | - | - | - | |
| Last Close Price | 1.77 | 3.40 | 4.90 | - | - | - | |
| PS Ratio | 35.64 | 106.38 | 146.86 | - | - | - | |
| PB Ratio | 3.64 | 5.92 | 6.63 | - | - | - | |
| P/TBV Ratio | 3.68 | 6.04 | 6.64 | - | - | - | |
| EV/Sales Ratio | 32.39 | 93.59 | 127.72 | - | - | - | |
| Debt / Equity Ratio | 0.07 | 0.05 | 0.04 | 7.20 | 1.26 | 6.27 | |
| Asset Turnover | 0.08 | 0.05 | 0.06 | 0.06 | 0.02 | 0.02 | |
| Inventory Turnover | 0.07 | 0.04 | 0.01 | 0.02 | 0.01 | 0.03 | |
| Quick Ratio | 4.31 | 8.39 | 12.83 | 0.39 | 0.86 | 0.35 | |
| Current Ratio | 5.81 | 9.89 | 14.08 | 0.60 | 1.12 | 0.54 | |
| Return on Equity (ROE) | -42.33% | -24.86% | -69.87% | -197.08% | -133.79% | -161.72% | |
| Return on Assets (ROA) | -22.85% | -17.44% | -27.30% | -20.55% | -21.98% | -24.47% | |
| Return on Capital (ROIC) | -24.06% | -18.46% | -29.12% | -21.82% | -23.38% | -27.26% | |
| Return on Capital Employed (ROCE) | -46.00% | -33.10% | -33.00% | -175.10% | -55.30% | -120.90% | |
| Earnings Yield | -14.12% | -4.70% | -5.54% | - | - | - | |
| FCF Yield | -15.08% | -7.68% | -4.81% | - | - | - | |
| Buyback Yield / Dilution | - | -8.56% | -34.30% | -14.14% | -17.59% | -6.22% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.